Pneumonia breathing treatment
Pro Research Analysisby 
Searched over 200M research papers
Pneumonia Breathing Treatment: Insights from Recent Research
Community-Based Amoxicillin Treatment for Fast-Breathing Pneumonia
Amoxicillin Efficacy in Young Infants
A cluster-randomized trial conducted in rural Bangladesh, Ethiopia, India, and Malawi evaluated the effectiveness of community-level health workers (CLHWs) administering a 7-day course of oral amoxicillin to young infants (7-59 days old) with fast-breathing pneumonia. The study found that the treatment by CLHWs was non-inferior to the standard referral strategy, with treatment failure rates of 5.4% in the intervention group compared to 6.3% in the control group .
Shorter Amoxicillin Courses in Older Children
In rural Pakistan, a study compared the effectiveness of a 3-day course of oral amoxicillin versus a 5-day course of cotrimoxazole for children aged 2-59 months with fast-breathing pneumonia. The results indicated that amoxicillin was as effective as cotrimoxazole, with primary treatment failure rates of 2.9% and 4%, respectively . Another study in Karachi, Pakistan, found that a 3-day course of amoxicillin was superior to placebo, with treatment failure rates of 2.6% for amoxicillin compared to 4.9% for placebo .
Amoxicillin vs. Placebo in African Settings
A trial in Malawi assessed the efficacy of amoxicillin versus placebo in children aged 2-59 months with non-severe fast-breathing pneumonia. The study concluded that amoxicillin was significantly more effective, with a treatment failure rate of 4% compared to 7% for placebo . Similarly, a multicenter trial in Pakistan found no significant difference in treatment failure rates between amoxicillin and placebo, suggesting that many children might not need antibiotics .
Chest Physiotherapy for Pneumonia
Efficacy in Adults
A randomized clinical trial evaluated the efficacy of chest physiotherapy and intermittent positive-pressure breathing in adults with pneumonia. The study found no significant difference in the duration of fever, extent of radiographic clearing, duration of hospital stay, or mortality between the treatment and control groups, suggesting that chest physiotherapy does not hasten pneumonia resolution in adults .
Efficacy in Children
The effectiveness of chest physiotherapy in children with pneumonia remains inconclusive. A Cochrane review included six randomized controlled trials (RCTs) involving 559 children and found no reliable evidence to support the routine use of chest physiotherapy. The studies varied in their methodologies and outcomes, making it difficult to draw definitive conclusions Chaves2013Ginsburg2018.
Conclusion
Recent research highlights the effectiveness of community-based amoxicillin treatment for fast-breathing pneumonia in young infants and children, with shorter courses proving to be as effective as longer ones. However, the role of chest physiotherapy in treating pneumonia remains uncertain, with studies showing no significant benefits in both adults and children. These findings suggest a need for further research to optimize pneumonia treatment strategies, particularly in low-resource settings.
Sources and full results
Most relevant research papers on this topic
Chest physiotherapy for pneumonia in children.
Chest physiotherapy may improve respiratory rate and oxygen saturation in children with pneumonia, but its effectiveness in reducing hospital stay duration and time to clinical resolution remains unclear due to limited data.
Comparison of oral amoxicillin with placebo for the treatment of world health organization-defined nonsevere pneumonia in children aged 2-59 months: a multicenter, double-blind, randomized, placebo-controlled trial in pakistan.
Children aged 2-59 months with WHO-defined nonsevere pneumonia do not experience a different clinical outcome when treated with antibiotics or placebo.
DOI